All posts by admin

14Jan/14

3 Reasons to Buy Gilead Sciences, Inc. – Motley Fool

3 Reasons to Buy Gilead Sciences, Inc.
Motley Fool
Last December, Gilead announced that a late-stage trial for idelalisib was stopped early because patients receiving a combo of idelalisib plus rituximab showed a highly significant improvement in overall survival and progression-free survival. With the …
Standard Review for Gilead’s Oncology Candidate – Analyst BlogNASDAQ
Gilead’s Idelalisib NDA accepted by US FDA for the treatment of refractory …MENAFN.COM

all 12 news articles »

14Jan/14

Standard Review for Gileads Oncology Candidate – Zacks.com

Standard Review for Gileads Oncology Candidate
Zacks.com
The patients were refractory to both Roche’s (RHHBY) Rituxan (rituximab) and to chemotherapy inclusive alkylating-agent. A decision from the FDA is expected by Sep 11, 2014. Apart from iNHL, idelalisib is also being evaluated in other oncology …
Gilead’s Idelalisib NDA accepted by US FDA for the treatment of refractory …MENAFN.COM

all 2 news articles »